Ileal glucose infusion leads to increased insulin sensitivity and decreased blood glucose levels in Wistar rats. 2014

Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
1Department of Surgery, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, Japan.

OBJECTIVE Rerouting of nutrients and/or increasing nutrient delivery to the small intestine after Roux-en-Y gastric bypass may have important potential as a diabetes treatment modality. However, it is still important question which part of the gastrointestinal tract is the most important for control of glycemia. The aim of this study was to investigate the role of different segments of the gastrointestinal tract on glucose metabolism in the physiological state. METHODS Forty 12-week-old male Wistar rats were divided into the following four groups of 10 animals each: the gastrostomy group, the duodenostomy group, the jejunostomy group, and the ileostomy group. All rats were subjected to a glucose tolerance test by infusion of glucose via the surgically inserted tubes in the stomach (gastrostomy), in the duodenum (duodenostomy), in the jejunum (jejunostomy), or in the ileum (ileostomy). Plasma glucagon-like peptide-17-36 (GLP-17-36) and insulin levels during the glucose tolerance test were assayed and Matsuda index was calculated. RESULTS Ileostomy rats exhibited significantly lower glycemic excursions compared with gastrostomy, duodenostomy, and jejunostomy rats. Insulin and GLP-1 levels during the glucose tolerance test were significantly higher in duodenostomy and jejunostomy rats than in gastrostomy and ileostomy rats. Matsuda index was significantly higher in ileostomy rats than in duodenostomy and jejunostomy rats. CONCLUSIONS Ileal glucose infusion leads to increased insulin sensitivity, further decreasing blood glucose levels.

UI MeSH Term Description Entries
D007081 Ileostomy Surgical creation of an external opening into the ILEUM for fecal diversion or drainage. This replacement for the RECTUM is usually created in patients with severe INFLAMMATORY BOWEL DISEASES. Loop (continent) or tube (incontinent) procedures are most often employed. Loop Ileostomy,Tube Ileostomy,Continent Ileostomy,Incontinent Ileostomy,Continent Ileostomies,Ileostomies,Ileostomies, Continent,Ileostomies, Incontinent,Ileostomies, Loop,Ileostomies, Tube,Ileostomy, Continent,Ileostomy, Incontinent,Ileostomy, Loop,Ileostomy, Tube,Incontinent Ileostomies,Loop Ileostomies,Tube Ileostomies
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007582 Jejunostomy Surgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation. Jejunostomies
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004385 Duodenostomy Surgical formation of an opening into the DUODENUM. Duodenostomies
D005774 Gastrostomy Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression. Gastrostomies

Related Publications

Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
October 2002, Canadian journal of physiology and pharmacology,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
January 1975, Acta physiologica Academiae Scientiarum Hungaricae,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
January 1972, Problemy endokrinologii,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
October 2011, Journal of neurosurgical anesthesiology,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
January 1979, Nutrition and metabolism,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
July 2016, Addiction biology,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
October 1996, The American journal of physiology,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
May 1988, Biulleten' eksperimental'noi biologii i meditsiny,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
January 2008, European journal of pharmacology,
Vo Nguyen Trung, and Hiroshi Yamamoto, and Satoshi Murata, and Atsukazu Kuwahara, and Tohru Tani
June 2002, European journal of endocrinology,
Copied contents to your clipboard!